| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Regadenoson |
| Brand | Rapiscan® |
| Indication | Cost-effectiveness of Regadenoson (Rapiscan®) |
| Assessment Process | |
| Rapid review commissioned | 19/09/2011 |
| Rapid review completed | 02/11/2011 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended |